John N. Gitonga

1.3k total citations
12 papers, 179 citations indexed

About

John N. Gitonga is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, John N. Gitonga has authored 12 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 4 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in John N. Gitonga's work include Viral Infections and Vectors (5 papers), Viral Infections and Outbreaks Research (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). John N. Gitonga is often cited by papers focused on Viral Infections and Vectors (5 papers), Viral Infections and Outbreaks Research (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). John N. Gitonga collaborates with scholars based in United Kingdom, Kenya and United States. John N. Gitonga's co-authors include Firoze Manji, Henry Karanja, George M. Warimwe, Daisy Mugo, Daniel Wright, Thomas A. Bowden, Charles N. Agoti, Francis Mulaa, Margaret Warren-Perry and David S. Peterson and has published in prestigious journals such as Nature Communications, PLoS ONE and PLoS Medicine.

In The Last Decade

John N. Gitonga

12 papers receiving 170 citations

Peers

John N. Gitonga
Mehul Kumar Chourasia United Kingdom
John N. Gitonga
Citations per year, relative to John N. Gitonga John N. Gitonga (= 1×) peers Mehul Kumar Chourasia

Countries citing papers authored by John N. Gitonga

Since Specialization
Citations

This map shows the geographic impact of John N. Gitonga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John N. Gitonga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John N. Gitonga more than expected).

Fields of papers citing papers by John N. Gitonga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John N. Gitonga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John N. Gitonga. The network helps show where John N. Gitonga may publish in the future.

Co-authorship network of co-authors of John N. Gitonga

This figure shows the co-authorship network connecting the top 25 collaborators of John N. Gitonga. A scholar is included among the top collaborators of John N. Gitonga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John N. Gitonga. John N. Gitonga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ngetsa, Caroline, Victor Osoti, Henry Karanja, et al.. (2023). Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR. PLoS ONE. 18(2). e0280685–e0280685. 5 indexed citations
2.
Jenkin, Daniel, Daniel Wright, Pedro M. Folegatti, et al.. (2023). Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial. The Lancet Infectious Diseases. 23(8). 956–964. 14 indexed citations
3.
Nyagwange, James, Kennedy Mwai, Henry Karanja, et al.. (2022). Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro. International Journal of Infectious Diseases. 127. 11–16. 4 indexed citations
4.
Otiende, Mark, Symon M. Kariuki, Donwilliams O. Omuoyo, et al.. (2022). Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014–2018: A cohort study. PLoS Medicine. 19(5). e1003994–e1003994. 7 indexed citations
5.
Nyagwange, James, Kennedy Mwai, Henry Karanja, et al.. (2021). Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations. Journal of Clinical Virology. 146. 105061–105061. 5 indexed citations
6.
Otiende, Mark, Donwilliams O. Omuoyo, George Githinji, et al.. (2021). Endemic chikungunya fever in Kenyan children: a prospective cohort study. BMC Infectious Diseases. 21(1). 186–186. 19 indexed citations
7.
Bottomley, Christian, Mark Otiende, Sophie Uyoga, et al.. (2021). Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels. Nature Communications. 12(1). 6196–6196. 13 indexed citations
8.
Wright, Daniel, Elizabeth Allen, M. Clark, et al.. (2020). Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein. iScience. 23(11). 101669–101669. 26 indexed citations
9.
Kamau, Everlyn, Charles N. Agoti, Joyce M. Ngoi, et al.. (2019). Complete Genome Sequences of Dengue Virus Type 2 Strains from Kilifi, Kenya. Microbiology Resource Announcements. 8(4). 10 indexed citations
10.
Stanback, John, Tara Nutley, John N. Gitonga, & Zahida Qureshi. (1999). Menstruation requirements as a barrier to contraceptive access in Kenya.. PubMed. 76(3). 124–6. 6 indexed citations
11.
Khan, Baldip, Sabah A. Omar, Margaret Warren-Perry, et al.. (1997). Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene. 91(4). 456–460. 24 indexed citations
12.
Manji, Firoze, et al.. (1984). The occurrence and distribution of fluoride in groundwaters of Kenya.. PubMed. 61(7). 503–12. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026